These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22745377)

  • 1. Retinal laser burn-induced neuropathy leads to substance P-dependent loss of ocular immune privilege.
    Lucas K; Karamichos D; Mathew R; Zieske JD; Stein-Streilein J
    J Immunol; 2012 Aug; 189(3):1237-42. PubMed ID: 22745377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal laser burn disrupts immune privilege in the eye.
    Qiao H; Lucas K; Stein-Streilein J
    Am J Pathol; 2009 Feb; 174(2):414-22. PubMed ID: 19147817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
    D'Orazio TJ; Mayhew E; Niederkorn JY
    J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
    D'Orazio TJ; Niederkorn JY
    Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
    Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
    Skelsey ME; Mellon J; Niederkorn JY
    J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10.
    Ashour HM; Niederkorn JY
    J Immunol; 2006 Dec; 177(12):8331-7. PubMed ID: 17142729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
    Wilbanks GA; Mammolenti M; Streilein JW
    J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes.
    Li XY; Niederkorn JY
    Ocul Immunol Inflamm; 1997 Dec; 5(4):245-57. PubMed ID: 9455741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation.
    Ashour HM; Niederkorn JY
    J Immunol; 2006 May; 176(10):5950-7. PubMed ID: 16670303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior Chamber-Associated Immune Deviation (ACAID): An Acute Response to Ocular Insult Protects from Future Immune-Mediated Damage?
    Cone RE; Pais R
    Ophthalmol Eye Dis; 2009; 1():33-40. PubMed ID: 23861608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and Molecular Mechanisms of Anterior Chamber-Associated Immune Deviation (ACAID): What We Have Learned from Knockout Mice.
    Vendomèle J; Khebizi Q; Fisson S
    Front Immunol; 2017; 8():1686. PubMed ID: 29250068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural control of ocular immune privilege.
    Streilein JW; Okamoto S; Sano Y; Taylor AW
    Ann N Y Acad Sci; 2000; 917():297-306. PubMed ID: 11268357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.